One stock that's trending within range of triggering a near-term breakout trade is
(AFFY), a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. This stock has been destroyed by the sellers so far in 2013, with shares off by a whopping 85%.
Shares of AFFY were pounded lower by 85% on Monday after reports of severe allergic reactions in some kidney-disease patients, culminating in at least five deaths, prompted the firm to recall its flagship antianemia drug Omontys.
>>4 Stocks Under $10 Moving Higher
If you take a look at the chart for Affymax, you'll see that this stock gapped down huge on Monday with massive downside volume, from over $16 to its recent low of $2.34 a share. Following that gap down in price, shares of AFFY have rebounded slightly to its recent high of $2.82 a share. This stock has now entered extremely oversold territory, since its current relative strength index reading is 11.33. Oversold can always get more oversold, but it's also an area where a stock can experience a powerful bounce higher from.
Traders should now look for long-biased trades in AFFY if it manages to break out above some near-term overhead resistance at $2.82 a share high volume. Look for a sustained move or close above $2.82 a share with volume that hits near or above its three-month average action of 2.41 million shares. If that breakout triggers soon, then I expect to see a very large tradable bounce that could easily spike shares of AFFY by 30% to 40%.
Traders can look to buy AFFY off any weakness to anticipate that breakout and simply use a stop that sits just below $2.34 a share. One could also buy off strength once AFFY takes out $2.82 a share with volume and then simply use a stop that that's a reasonable percentage from your entry.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts